JPRN-C000000273Completed未知
Concurrent Chemoradiotherapy with Cisplatin and Docetaxel for Advanced Head and Neck Cancer Phase II Study - Concurrent Chemoradiotherapy with Cisplatin and Docetaxel for Advanced Head and Neck Cancer Phase II Study
Department of Otolaryngology, Osaka University School of Medicine0 sites160 target enrollmentStarted: March 1, 2006Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 160
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to 75years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1) interstitial pneumonia or pulmonary fibrosis evidenced by chest X-ray and/or chest CT 2) major heart/lung disorders, or uncontrolled diabetes mellitus 3) distant metastases or second primary cancer except when there has been no evidence of the disease for more than 24 months without any treatment 4) major pulmonary effusion or ascites 5) neuropathy or edema 6) pregnancy or lactation 7) history of major allergy to medicine 8) long use of steroid
Investigators
Similar Trials
Active, not recruiting
Not Applicable
Radiotherapy and chemotherapy with cisplatin and temozolomide for patients affected by primary glioblastoma of new diagnosis - NDPrimary GLIOBLASTOMA of first diagnosisMedDRA version: 9.1Level: PTClassification code 10018336MedDRA version: 9.1Level: SOCClassification code 10029205EUCTR2008-000380-42-ITISTITUTO NEUROLOGICO CARLO BESTA
Completed
Phase 2
Treatment outcome in head and neck cancer patients receiving carboplatin plus capecitabine based versus high dose cisplatin based chemoradiotherapy.CTRI/2020/11/029290Govt Kilpauk Medical College81
Recruiting
Phase 2
Induction chemoradiotherapy with cisplatin plus vinorelbine and irradiation, followed by surgery in cT1-3N2M0, stage IIIA non-small cell lung cancer.on-small cell lung cancerJPRN-UMIN000005416Kyoto University Hospital35
Not yet recruiting
Not Applicable
Concurrent chemoradiotherapy with paclitaxel and carboplatin for stage III or IVA cervical cancer with renal dysfunctioocally advanced stage III or IVA cervical cancer with renal dysfunctionJPRN-UMIN000026034Yokohama City University32
Recruiting
Phase 2
DCF-RT for T4b ECLocally advanced esophageal cancerEsophageal cancerJPRN-jRCTs051190058Miyata Hiroshi20